Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Snapinn

Pharmaceutical statistics

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pharmaceutical Statistics|September 30, 2011
Indirect comparisons in the comparative efficacy and non-inferiority settingsSteven Snapinn, Qi Jiang
Pharmaceutical Statistics|October 7, 2022
Treatment effect measures under nonproportional hazardsSteven Snapinn, Qi Jiang, Chunlei Ke
Pharmaceutical Statistics|November 28, 2006
Assessment of futility in clinical trialsSteven Snapinn, Mon-Gy Chen, Qi Jiang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pharmaceutical Statistics|September 30, 2011
Indirect comparisons in the comparative efficacy and non-inferiority settingsSteven Snapinn, Qi Jiang
Pharmaceutical Statistics|October 7, 2022
Treatment effect measures under nonproportional hazardsSteven Snapinn, Qi Jiang, Chunlei Ke
Pharmaceutical Statistics|November 28, 2006
Assessment of futility in clinical trialsSteven Snapinn, Mon-Gy Chen, Qi Jiang, et al.
Pageof 1